Ongoing Product Development in Biotechnology to Flourish Global Cell Processing Instruments Market

Global cell processing instrument market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). The growing demand for innovative treatment options for chronic disorders and an increasing focus on regenerative medicine a key factors driving the growth of the global cell processing instrument market. Cell-based therapies offer potential cures or effective management options, and the growing demand for infrastructure and tools for developing and delivering these treatments fuels the market for cell processing instruments. 

Browse the full report description of “Cell Processing Instrument Market Size, Share & Trends Analysis Report by Type (Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, and Other Instruments), by Application (Cell Isolation/Separation, Cell Imaging & Counting, Cell Viability & Proliferation, and Other Applications), and by End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academic & Research Institutes, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/cell-processing-instrument-market

In November 2023, Sandoz Group AG launched a high-concentration formulation (HCF) of Hyrimoz (adalimumab) for treating Crohn's disease in Europe. The medicine is indicated for all conditions covered by the reference medicine, including rheumatic diseases, Crohn's disease, ulcerative colitis, plaque psoriasis, uveitis, and hidradenitis suppurativa. Sandoz's President of Europe, Rebecca Guntern, said the launch is a key milestone in expanding access to high-quality medicines. The launch strengthens Sandoz's immunology biosimilar portfolio, including Erelzi, Zessly, and Rixathon.

Further, in October 2023, Molecular Devices, LLC, announced the launch of CellXpress.ai automated cell culture system. This application is anticipated to increase the drug discovery rate. Furthermore, in January 2023, Curate Biosciences announced the launch of, the curate cell processing system, which is a one-of-a-kind system designed to produce high-quality starting materials for various cell therapies, including CAR-T cancer therapies.

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Type

o By Application

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- includes Agilent Technologies Inc., Danaher Corp., Thermo Scientific Inc., Merck KGaA, and Beckman Coulter, Inc. among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cell Processing Instrument Market Report Segment

By Type

• Cell Counters
• Cell Imaging Systems
• Flow Cytometers
• Cell Separator Systems
• Automated Cell Processing Systems
• Other Instruments (Centrifuges, and CO2 Incubators)

By Application

• Cell Isolation/Separation
• Cell Imaging & Counting
• Cell Viability & Proliferation
• Other Applications (Cell Harvesting)

By End-User

• Pharmaceutical & Biotechnology Companies
• CROs & CMOs
• Academic & Research Institutes

Global Cell Processing Instrument Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-processing-instrument-market